Viridian Therapeutics(VRDN) - 2022 Q1 - Earnings Call Transcript

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants John Jordan - VP, Investor Relations and Corporate Communications Jonathan Violin - CEO, President & Director Kristian Humer - CFO, Chief Business Officer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Christopher Howerton - Jefferies Thomas Smith - SVB Leerink Laura Chico - Wedbush Securities Rami Katkhuda - LifeSci Capital Jason Butler - JMP Secu ...